DIGITAL EDITION

ARCHIVES

Category: Departments

Compulsive Biting and Chewing with Mixed Amphetamine Salts: A Case Report

by Melissa Free, MD; Hena Choi, BA; and Ritika Baweja, MD Drs. Free and Baweja are with Department of Psychiatry and Behavioral Health, Penn State Health Milton S. Hershey Medical

GLP-1 Agonists Can Affect Mood: A Case of Worsened Depression on Ozempic (Semaglutide)

by Senthil Vel Rajan Rajaram Manoharan, MD, and Rohit Madan, MD Dr. Manoharan is with Huntsville Hospital/University of Alabama at Birmingham – Huntsville Campus in Huntsville, Alabama. Dr. Madan is

The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics

by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA, BCGP, BCPP; EILEEN TRIGOBOFF, RN, PMHCNS-BC, DNS, DABFN; and CLAUDIA LEE, MD Dr. O’Donnell is with Edward Hines Jr. Veterans

Risk Management: EHR Use and Emerging Risks

by Justin A. Pope, JD Mr. Pope is a Senior Risk Manager at Professional Risk Management Services (PRMS). FUNDING: No funding was provided for the preparation of this article. DISCLOSURES:

Artificial Intelligence and Neurorehabilitation: Fact vs. Fiction

by Nicola Fiorente, MD; Sepehr Mojdehdehbaher, BSc; and Rocco Salvatore Calabrò, MD, PhD Dr. Fiorente is with Polimedica Fisio and Sport in Cittadella (PD), Italy. Dr. Mojdehdehbaher is with Engineering

Impact of COVID-19 Pandemic on Patients with Serious Mental Illness (SMI) and Nonpsychiatric Control Subjects in Clinical Trials

by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD Ms. Fe Garcia-Rada and Dr. Litman are with CenExel CBH Health in Gaithersburg, Maryland. Dr. Litman is additionally with Georgetown

Current and Emerging Technologies to Address the Placebo Response Challenge in CNS Clinical Trials: Promise, Pitfalls, and Pathways Forward

by William P. Horan, PhD; Gary Sachs, MD; Dawn I. Velligan, PhD; Michael Davis, MD, PhD; Richard S.E. Keefe, PhD; Ni A. Khin, MD; Florence Butlen-Ducuing, MD, PhD; and Philip

Ensuring Stakeholder Feedback in the Design and Conduct of Clinical Trials for Rare Diseases: ISCTM Position Paper of the Orphan Disease Working Group

by Gahan J. Pandina, PhD; Joan Busner, PhD; Lucas Kempf, MD; Joan Fallon, BS, DC; Larry D. Alphs, MD, PhD; Maria T. Acosta, MD; Anna-Karin Berger, PhD; Simon Day, PhD;

ChatGPT and Transcranial Direct Current Stimulation for Chronic Pain

by Edson Silva-Filho, PhD, and Rodrigo Pegado, PhD Both authors are with Graduate Program in Heath Science, Graduate Program in Physical Therapy, Federal University of Rio Grande do Norte in

Risk Management: Blurring the Lines—Boundary Violation

by Akemini “Kem” Isang, RN, JD Ms. Isang is a Risk Manager at Professional Risk Management Services (PRMS). Funding: No funding was provided for the preparation of this article. Disclosures: